company background image
ZTS * logo

Zoetis BMV:ZTS * Stock Report

Last Price

Mex$3.35k

Market Cap

Mex$1.5t

7D

-0.06%

1Y

-0.5%

Updated

02 Jan, 2025

Data

Company Financials +

ZTS * Stock Overview

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. More details

ZTS * fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance2/6
Financial Health4/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Zoetis Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Zoetis
Historical stock prices
Current Share PriceUS$3,350.50
52 Week HighUS$3,858.69
52 Week LowUS$2,483.00
Beta0.88
1 Month Change-7.44%
3 Month Change-8.21%
1 Year Change-0.55%
3 Year Change-27.65%
5 Year Change31.91%
Change since IPO115.88%

Recent News & Updates

Recent updates

Shareholder Returns

ZTS *MX PharmaceuticalsMX Market
7D-0.06%-1.8%0.4%
1Y-0.5%-26.7%-11.8%

Return vs Industry: ZTS * exceeded the MX Pharmaceuticals industry which returned -26.3% over the past year.

Return vs Market: ZTS * exceeded the MX Market which returned -12% over the past year.

Price Volatility

Is ZTS *'s price volatile compared to industry and market?
ZTS * volatility
ZTS * Average Weekly Movement5.4%
Pharmaceuticals Industry Average Movement6.3%
Market Average Movement4.1%
10% most volatile stocks in MX Market6.1%
10% least volatile stocks in MX Market2.8%

Stable Share Price: ZTS *'s share price has been volatile over the past 3 months compared to the MX market.

Volatility Over Time: ZTS *'s weekly volatility (5%) has been stable over the past year, but is still higher than 75% of MX stocks.

About the Company

FoundedEmployeesCEOWebsite
195214,100Kristin Peckwww.zoetis.com

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives.

Zoetis Inc. Fundamentals Summary

How do Zoetis's earnings and revenue compare to its market cap?
ZTS * fundamental statistics
Market capMex$1.51t
Earnings (TTM)Mex$50.05b
Revenue (TTM)Mex$188.52b

30.2x

P/E Ratio

8.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ZTS * income statement (TTM)
RevenueUS$9.15b
Cost of RevenueUS$2.74b
Gross ProfitUS$6.42b
Other ExpensesUS$3.99b
EarningsUS$2.43b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)5.39
Gross Margin70.09%
Net Profit Margin26.55%
Debt/Equity Ratio126.0%

How did ZTS * perform over the long term?

See historical performance and comparison

Dividends

1.2%

Current Dividend Yield

31%

Payout Ratio

Does ZTS * pay a reliable dividends?

See ZTS * dividend history and benchmarks
When do you need to buy ZTS * by to receive an upcoming dividend?
Zoetis dividend dates
Ex Dividend DateJan 21 2025
Dividend Pay DateMar 04 2025
Days until Ex dividend18 days
Days until Dividend pay date60 days

Does ZTS * pay a reliable dividends?

See ZTS * dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 11:55
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zoetis Inc. is covered by 43 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jasper HellwegArgus Research Company
Ishan MajumdarBaptista Research
Balaji PrasadBarclays